Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.

Studies show that bipolar disorder patients with severe symptoms demonstrate significant impairment in prospective memory – the ability to remember and execute planned future actions.

Only 5% of Wernicke encephalopathy cases are diagnosed before death, yet the condition is fatal in 20% of untreated patients and leads to Korsakoff syndrome in over half of survivors.

A multicenter trial reports that adding middle meningeal artery embolization to surgical evacuation reduced reoperation rates from 11.3% to 4.1% in subdural hematoma patients, though further safety evaluation is needed.

Phase 2a clinical trials demonstrate benfotiamine’s ability to enhance synaptic activity while maintaining an excellent safety profile, even at doses exceeding normal thiamine blood levels.

23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.